Skip to main content
Irfan Qureshi, MD, Neurology, Bronx, NY

IrfanAQureshiMD

Neurology Bronx, NY

Assistant Professor, Neurology, Albert Einstein College of Medicine

Are you Dr. Qureshi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 55 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    111 E 210th Street
    Bronx, NY 10467
    Phone+1 718-430-4288
    Fax+1 718-430-8551

Summary

  • Dr. Irfan Qureshi, MD is a board certified neurologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Burke Rehabilitation Hospital and is an Assistant Professor at Albert Einstein College of Medicine.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2003 - 2006
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of Biopharma
    Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of BiopharmaJuly 22nd, 2020
  • Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)
    Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)January 22nd, 2020
  • Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients Enrolled
    Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients EnrolledAugust 12th, 2019
  • Join now to see all